63629-3906 : Zaleplon 5 mg Oral Capsule


NDC: 63629-3906
Labeler: Bryant Ranch Prepack
Product Type: Human Prescription Drug
Drug Name:  Zaleplon
Dosage Form: Oral Capsule
Application #: NDA020859
Rev. Date: 
CSA Schedule: CIV (US) [1]


[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: cor;322
Shapes:  Capsule
Colors:  White
Size (mm): 14
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 63629-3906-1: 30 CAPSULE IN 1 BOTTLE (63629‑3906‑1)
  • 63629-3906-2: 60 CAPSULE IN 1 BOTTLE (63629‑3906‑2)
  • 63629-3906-3: 90 CAPSULE IN 1 BOTTLE (63629‑3906‑3)
  • 63629-3906-4: 20 CAPSULE IN 1 BOTTLE (63629‑3906‑4)
  • 63629-3906-5: 28 CAPSULE IN 1 BOTTLE (63629‑3906‑5)

Active Ingredients:

  • Zaleplon

Dosage Strength:

  • 5 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Starch, Corn
  • Silicon Dioxide
  • Sodium Lauryl Sulfate
  • Magnesium Stearate
  • Lactose
  • Gelatin
  • Titanium Dioxide
  • D&c Yellow No. 10
  • Fd&c Blue No. 1
  • Fd&c Green No. 3
  • Fd&c Yellow No. 5

Pharmaceutical Classes:

  • gamma-Aminobutyric Acid A Receptor Agonist [EPC]
  • GABA A Agonists [MoA]
  • Central Nervous System Depression [PE]

Related Products:

Based on records with the same trade name.
  • 63629-3405 Zaleplon 10 mg Oral Capsule by Bryant Ranch Prepack
  • 71335-0236 Zaleplon 5 mg Oral Capsule by Bryant Ranch Prepack
  • 71335-1054 Zaleplon 10 mg Oral Capsule by Bryant Ranch Prepack
  • 71335-1387 Zaleplon 10 mg Oral Capsule by Bryant Ranch Prepack
  • 71335-1466 Zaleplon 5 mg Oral Capsule by Bryant Ranch Prepack
  • 0054-0084 Zaleplon 5 mg Oral Capsule by Roxane Laboratories, Inc
  • 0054-0085 Zaleplon 10 mg Oral Capsule by Roxane Laboratories, Inc
  • 0093-5268 Zaleplon 5 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5269 Zaleplon 10 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0378-6805 Zaleplon 5 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-6810 Zaleplon 10 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0832-0400 Zaleplon 5 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 0832-0401 Zaleplon 10 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 16714-551 Zaleplon 5 mg Oral Capsule by Northstar Rx LLC
  • 16714-561 Zaleplon 10 mg Oral Capsule by Northstar Rx LLC
  • 21695-105 Zaleplon 10 mg Oral Capsule by Rebel Distributors Corp.
  • 21695-376 Zaleplon 5 mg Oral Capsule by Rebel Distributors Corp.
  • 29300-131 Zaleplon 5 mg Oral Capsule by Unichem Pharmaceuticals (Usa), Inc.
  • 29300-132 Zaleplon 10 mg Oral Capsule by Unichem Pharmaceuticals (Usa), Inc.
  • 33261-454 Zaleplon 10 mg/1 Oral Capsule by Aidarex Pharmaceuticals LLC
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63629-3906 QR Code

< Prev: 63629-3871Next: 63629-3910 >

Related Discussions:

chemistry of zaleplon
all information about production & qc of zaleplon ## Zaleplon (marketed under the brand names Sonata and Starnoc) is... 1 reply
How can I disolve Zaleplon
I want to be able to put a 10 mg cap of Zaleplon in a liquid, drink 1/2 refrigerate and drink the other 1/2 the next nig... 1 reply
zaleplon
sonata...
Starnoc/Zaleplon
Why has Starnoc/Zaleplon been discontinued in Canada?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.